HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stefan Seidl Selected Research
Stefan Seidl Research Topics
Disease
5
Neoplasms (Cancer)
01/2010 - 04/2002
3
Inflammation (Inflammations)
02/2014 - 02/2008
3
Aneurysm (Aneurysms)
09/2009 - 08/2008
2
Carcinogenesis
07/2010 - 05/2008
2
Stomach Neoplasms (Stomach Cancer)
05/2008 - 07/2007
2
Carcinoma (Carcinomatosis)
05/2008 - 07/2007
1
Carotid Stenosis (Carotid Artery Stenosis)
02/2014
1
Carotid Artery Diseases
02/2014
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2010
1
Infertility (Sterility)
01/2010
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010
1
Stillbirth
01/2010
1
Maternal Death
01/2010
1
Vascular Diseases (Vascular Disease)
09/2009
1
Vascular Malformations
09/2009
1
Infections
09/2009
1
Arteritis
09/2009
1
Wounds and Injuries (Trauma)
09/2009
1
Hyperplasia
01/2009
1
Vascular Remodeling
01/2009
1
Abdominal Aortic Aneurysm
01/2009
1
Acute Kidney Injury (Acute Renal Failure)
07/2008
1
Atherosclerotic Plaque (Atheroma)
07/2008
1
Myocardial Infarction
05/2008
1
Adenocarcinoma
05/2008
1
Hypoxia (Hypoxemia)
04/2008
1
Neointima
02/2008
1
Vascular System Injuries
02/2008
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2007
1
Atherosclerosis
04/2007
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2007
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2006
1
Pancreatitis
04/2005
1
Heart Diseases (Heart Disease)
04/2005
1
Hepatitis
04/2005
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
07/2008 - 07/2007
2
Integrins
IBA
02/2014 - 05/2008
2
Matrix Metalloproteinases (MMPs)
IBA
01/2009 - 08/2008
2
Integrin beta3 (GPIIIa)
IBA
05/2008 - 04/2008
2
Integrin alphaVbeta3
IBA
05/2008 - 04/2008
2
Cadherins (E-Cadherin)
IBA
05/2008 - 07/2007
2
Peptides (Polypeptides)
IBA
04/2008 - 02/2008
1
Ligands
IBA
07/2010
1
ErbB Receptors (EGF Receptor)
IBA
07/2010
1
Collagen
IBA
09/2009
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2009
1
TOR Serine-Threonine Kinases
IBA
01/2009
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2009
1
Collagen Type III (Type III Collagen)
IBA
07/2008
1
Collagen Type I (Type I Collagen)
IBA
07/2008
1
Collagen Receptors
IBA
07/2008
1
platelet membrane glycoprotein VI
IBA
07/2008
1
rho GTP-Binding Proteins (rho GTP-Binding Protein)
IBA
05/2008
1
Cytotoxins (Cytolysins)
IBA
04/2008
1
fluoroazomycin arabinoside
IBA
04/2008
1
azomycin
IBA
04/2008
1
carbogen
IBA
04/2008
1
member 1 small inducible cytokine subfamily E
IBA
02/2008
1
Sirolimus (Rapamycin)
FDA Link
02/2008
1
Cytokines
IBA
02/2008
1
Everolimus
FDA Link
02/2008
1
Histamine (Histamine Dihydrochloride)
FDA Link
09/2007
1
Antibodies
IBA
07/2007
1
Serine Proteases (Serine Protease)
IBA
04/2007
1
PAR-2 Receptor
IBA
04/2007
1
matriptase
IBA
04/2007
1
Interleukin-6 (Interleukin 6)
IBA
04/2007
1
Chemokine CX3CL1
IBA
01/2007
1
Antiviral Agents (Antivirals)
IBA
04/2005
Therapy/Procedure
3
Therapeutics
11/2006 - 04/2002
1
Carotid Endarterectomy
02/2014
1
Aftercare (After-Treatment)
01/2010
1
Drug Therapy (Chemotherapy)
01/2010
1
Adjuvant Chemotherapy
01/2010
1
Radiotherapy
07/2008
1
Esophagectomy
07/2008
1
Lymph Node Excision (Lymph Node Dissection)
07/2008
1
Neoadjuvant Therapy
07/2008
1
Percutaneous Coronary Intervention
02/2008